Hydralazine Hydrochloride
NDC 0517-0901, Hydralazine Hydrochloride, injection, solution, from American Regent, Inc..
- Product NDC
- 0517-0901
- Status
- Listed
- Labeler
- American Regent, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040136
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0517-0901 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE20 mg/mL
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0517-0901-25 | 00517090125 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-0901-25) / 1 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/17210abc-58f6-442e-8ff2-7971333c82f6Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0517-0901
Use it
Look up 0517-0901 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0517-0901 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0517-0901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.